Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
24 hedge funds and large institutions have $36.7M invested in Alpine Immune Sciences Inc in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 23 → 24 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
39% less capital invested
Capital invested by funds: $59.9M → $36.7M (-$23.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$472K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$123K |
| 3 |
Renaissance Technologies
New York
|
+$60.1K |
| 4 |
LRIA
Leonard Rickey Investment Advisors
Yakima,
Washington
|
+$57.8K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$344K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$289K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$245K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$20.3K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
-$9.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | +$81 | +14 | New |
|
ALPN Hedge Fund Activity: Q2 2019 in Review
24 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2019, worth a combined $36.7M — down 39% from $59.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ALPN positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $472K. The largest seller was Deerfield Management, cutting an estimated $344K.
- 24 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2019, up from 23 in Q1 2019.
- Funds reported $36.7M of Alpine Immune Sciences Inc stock for Q2 2019, down 39% quarter-over-quarter.
- 3 funds opened new Alpine Immune Sciences Inc positions in Q2 2019 and 2 closed out, a net change of +1 holder.
- The largest Alpine Immune Sciences Inc buyer in Q2 2019 was Vanguard Group, an estimated $472K added.
- The largest Alpine Immune Sciences Inc seller in Q2 2019 was Deerfield Management, an estimated $344K sold.
Based on aggregated 13F filings for Q2 2019.